Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.43 |
| ▸ | TYMP | P19971 | 1/20 | 0.42 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6536213 | 0.92 | TK1 (0.42) | TK1TYMP | |
| SCHEMBL28239487 | 0.91 | TK1 (0.41) | TK1TYMP | |
| SCHEMBL27651863 | 0.91 | TK1 (0.41) | TK1TYMP | |
| SCHEMBL5148089 | 0.88 | RNASE1 (0.46) | TK1TYMPRNASE1 | |
| SCHEMBL28293851 | 0.88 | TK1 (0.39) | TK1TYMPRNASE1 | |
| SCHEMBL17224727 | 0.87 | TK1 (0.39) | TK1TYMPRNASE1 | |
| SCHEMBL8744125 | 0.86 | TK1 (0.38) | TK1TYMP | |
| SCHEMBL28040328 | 0.86 | PYGM (0.45) | TK1 | |
| SCHEMBL5709920 | 0.85 | TK1 (0.40) | TK1TYMPRNASE1 | |
| SCHEMBL8744135 | 0.85 | TK1 (0.38) | TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4447934-B1 | CARRIER AS A MULTIFUNCTIONAL SYSTEM | LIFESOME THERAPEUTICS SL (ES) | 2025-08-06 | — | — | EP | claimed |
| EP-4294365-A1 | USE OF A PEMETREXED CONCENTRATE SOLUTION | STADA ARZNEIMITTEL AG (DE) | 2023-12-27 | — | — | EP | disclosed |
| EP-4213899-A1 | TISSUE ADHESIVE FOR USE IN A TREATMENT METHOD IN WHICH AN OPHTHALMOLOGICAL IMPLANT IS IMPLANTED IN A HUMAN OR ANIMAL PATIENT, AND OPHTHALMOLOGICAL IMPLANTATION SYSTEM | Carl Zeiss Meditec AG (DE) | 2023-07-26 | — | — | EP | disclosed |
| WO-2022175463-A1 | USE OF A PEMETREXED CONCENTRATE SOLUTION | STADA ARZNEIMITTEL AG (DE) | 2022-08-25 | — | — | WO | disclosed |
| EP-4046626-A1 | USE OF A PEMETREXED CONCENTRATE SOLUTION | STADA Arzneimittel AG (DE) | 2022-08-24 | — | — | EP | disclosed |
| WO-2022058247-A1 | TISSUE ADHESIVE FOR USE IN A TREATMENT METHOD IN WHICH AN OPHTHALMOLOGICAL IMPLANT IS IMPLANTED IN A HUMAN OR ANIMAL PATIENT, AND OPHTHALMOLOGICAL IMPLANTATION SYSTEM | CARL ZEISS MEDITEC AG (DE) | 2022-03-24 | — | — | WO | disclosed |
| US-20100317004-A1 | PROBES | Life Technologies Corporation (US) | 2010-12-16 | — | — | US | disclosed |
| EP-1585835-B1 | Nucleic acid probes and method for detecting a target nucleic acid sequence comprising two or more cis-located nucleic acid regions | DYNAL BIOTECH LTD (GB) | 2007-04-18 | — | — | EP | disclosed |
| US-20060269916-A1 | Probes | DYNAL BIOTECH INC. | 2006-11-30 | — | — | US | disclosed |
| EP-1585835-A2 | NUCLEIC ACID PROBES AND METHOD FOR DETECTING A TARGET NUCLEIC ACID SEQUENCE COMPRISE TWO OR MORE CIS- LOCATED NUCLEIC ACID REGIONS | Dynal Biotech Limited (GB) | 2005-10-19 | — | — | EP | disclosed |
| WO-2004048611-A2 | NUCLEIC ACID PROBES AND METHOD FOR DETECTING A TARGET NUCLEIC ACID SEQUENCE COMPRISE TWO OR MORE CIS- LOCATED NUCLEIC ACID REGIONS | DYNAL BIOTECH LIMITED (GB) | 2004-06-10 | — | — | WO | disclosed |
| EP-0734391-B1 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS INC (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1201676-A2 | PNA-DNA-PNA chimeric macromolecules | ISIS PHARMACEUTICALS, INC. (US) | 2002-05-02 | — | — | EP | disclosed |
| US-6277603-B1 | PEPTIDE NUCLEIC ACID (PNA); THE DNA PORTION IS COMPOSED OF SUBUNITS OF AT LEAST ONE 2'-DEOXYNUCLEOTIDES; INCREASED NUCLEASE RESISTANCE; ACTIVATE RNASE H ENZYME, USE FOR IN VITRO MODIFICATION OF RNA | ISIS PHARMACEUTICALS, INC. | 2001-08-21 | — | — | US | disclosed |
| EP-0734391-A4 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS INC (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5700922-A | INCREASED NUCLEASE RESISTANCE, INCREASED BINDING AFFINITY TO COMPLEMENTARY STRANDS; MEDICAL DIAGNOSIS, THERAPY | ISIS PHARMACEUTICALS, INC. (US) | 1997-12-23 | — | — | US | disclosed |
| EP-0734391-A1 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-02 | — | — | EP | disclosed |
| WO-1995014706-A1 | PNA-DNA-PNA CHIMERIC MACROMOLECULES | ISIS PHARMACEUTICALS, INC. (US) | 1995-06-01 | — | — | WO | disclosed |